Elekta Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Dive Deeper Into the Activities Behind the Analysis
This Elekta Value Chain Analysis gives a clear view of how Elekta creates value through its support and primary activities, making it useful for research, strategy, investing, or business planning. This page already shows a real preview of the actual analysis, not just promotional text, so you can review the format before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Elekta's Firm Infrastructure rests on global governance, quality systems, regulatory compliance, and tight capital allocation, which are core in a highly regulated medtech model. That backbone helps Elekta secure product approvals, control risk, and keep R&D, manufacturing, and service teams aligned. It also supports faster decision-making across markets where patient safety and audit trails matter most.
Human Resource Management
In FY2025, Elekta's human resource management still centers on scarce talent: engineers, software specialists, physicists, regulatory experts, and field service teams. Hiring and keeping these roles protects product reliability, clinical trust, and hospital uptime for complex installs. In a business with regulated medtech systems, one weak hire can slow launches, raise service risk, and hurt recurring revenue.
Technology Development
Elekta's technology development centers on radiation therapy, radiosurgery, brachytherapy, and oncology software, and it reported FY2024/25 net sales of about SEK 17 billion. Ongoing R&D helps raise dose precision, speed workflow, and tailor treatment plans. That matters because small gains in planning software and image guidance can lift throughput and patient outcomes. Elekta's edge comes from turning R&D into hospital-ready tools, not just new hardware.
Procurement
Elekta's procurement relies on qualified suppliers for precision components, electronics, imaging parts, and specialized inputs, because its systems must meet strict safety and performance rules. Tight sourcing controls support traceability, lower defect risk, and steadier costs across a medtech supply chain that is audited under quality standards such as ISO 13485. That matters in FY2025, when every weak link can hit delivery, service uptime, and margins.
Elekta FY2025: Compliance, R&D and sourcing drive growth
Elekta's support activities in FY2025 are built around compliant governance, scarce medtech talent, heavy R&D, and tightly controlled sourcing. Together they protect product safety, speed oncology software and hardware upgrades, and support service uptime across regulated markets. With FY2024/25 net sales of about SEK 17 billion, these functions remain central to margin and growth.
| FY2025 focus | Key data |
|---|---|
| Net sales | SEK 17bn |
| Core risk | Quality and compliance |
| Value driver | R&D-led precision |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Elekta's inbound logistics depend on a tightly managed supplier base for precision components, subassemblies, and software inputs, because even small defects can disrupt regulated medical-device traceability.
In FY2025, this matters at scale: Elekta reported about SEK 18 billion in annual revenue, so faster receiving, inspection, and lot control help protect uptime, lower scrap, and keep production of therapy systems on schedule.
Operations
Elekta's operations turn engineering into performance through design, assembly, testing, calibration, and regulatory validation of cancer treatment systems. In fiscal 2025, Elekta reported net sales of about SEK 17.3 billion, showing how much scale this quality gate supports. That work matters because it directly shapes clinical reliability, uptime, and serviceability in the field.
Quality control is not a side task here; it is the product.
Outbound Logistics
Elekta's outbound logistics move large radiotherapy and radiosurgery systems from plant to hospitals, cancer centers, and clinics, with tight site checks and install planning. These systems can weigh several tons, so transport safety and timing matter as much as the product itself.
Delays can hit clinical downtime windows and push back patient treatment starts, so Elekta uses coordinated delivery, staging, and on-site setup. In its FY2024/25 reporting, Elekta serves a global installed base of over 6,000 systems, which makes reliable outbound execution a core value-chain task.
Marketing and Sales
In Elekta's FY2024/25 marketing and sales, direct selling to hospitals, oncology networks, and clinicians is backed by clinical evidence and formal tender bids. Winning deals depends less on price and more on proven outcomes, software that speeds workflows, and strong service coverage. This fits Elekta's precision-radiation niche, where buyers assess total care impact over the full treatment cycle.
Service
Elekta's service layer covers installation, training, maintenance, remote support, and software updates, which keeps complex oncology systems running and clinicians using them correctly. In fiscal 2025, this after-sales work helped protect uptime and supported recurring revenue from a large installed base of radiation therapy and radiosurgery systems. It also lowers lifecycle risk for customers, since even short outages can disrupt patient throughput and delay treatment plans.
Elekta: Scaling Cancer Care with 6,000+ Systems
Elekta's primary activities center on building, selling, and supporting cancer treatment systems across design, assembly, testing, and installation. In FY2025, net sales were about SEK 17.3 billion, and the installed base topped 6,000 systems, so uptime and service quality matter at every step.
Sales are driven by direct tenders with hospitals and oncology networks, while service keeps systems calibrated, updated, and clinically reliable.
| Primary activity | FY2025 data | Why it matters |
|---|---|---|
| Operations | SEK 17.3 billion net sales | Shows scale of production quality |
| Service | 6,000+ installed systems | Drives uptime and recurring support |
Preview Before You Purchase
Elekta Reference Sources
This is the actual Elekta Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so you're seeing the same content before you buy. Once purchased, the complete Elekta Value Chain Analysis becomes available in full.
Frequently Asked Questions
Elekta's support base is strongest in technology development, procurement, and firm infrastructure. The business revolves around 3 therapy areas and oncology software, so quality systems and engineering coordination matter more than simple volume. That structure helps Elekta protect precision, manage regulated products, and keep 4 support activities aligned with 5 primary activities.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.